Metraipolis › archive › dc_6f210ae7f4ee

N4-acetylcytidine modification bridges metabolic reprogramming and immune evasion in cancer: mechanisms and therapeutic implications — Europe PMC PMID:42445196

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42445196
DOI
10.3389/fimmu.2026.1820962
License (as archived)
solo-consultazione
Archived
2026-10-31T07:47:37.255Z
SHA-256 of the archived text
4cb7e40917537f1073181abaed7c9bd1da2698964ad2d0bbd1ddac340e359558
Stable URL of this page
https://metraipolis.com/documento/dc_6f210ae7f4ee

How to cite

N4-acetylcytidine modification bridges metabolic reprogramming and immune evasion in cancer: mechanisms and therapeutic implications — Europe PMC PMID:42445196 — Europe PMC (en), https://europepmc.org/article/MED/42445196 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6f210ae7f4ee (Metraipolis archive dc_6f210ae7f4ee, sha256 4cb7e40917537f1073181abaed7c9bd1da2698964ad2d0bbd1ddac340e359558)
BibTeX
@misc{dc6f210ae7f4ee,
  title = {N4-acetylcytidine modification bridges metabolic reprogramming and immune evasion in cancer: mechanisms and therapeutic implications — Europe PMC PMID:42445196},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42445196},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6f210ae7f4ee; sha256 4cb7e40917537f1073181abaed7c9bd1da2698964ad2d0bbd1ddac340e359558},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42445196. Agents can read the archived copy with the MCP tool read_document.